Alpha DNA Investment Management’s Alkermes ALKS Stock Holding History

Alpha DNA Investment Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,186	Closed	-$694K	–	171
2023 Q2	$694K	Buy	+22,186	New	+$672K	0.23%	135
2021 Q2	–	Sell	-96	Closed	-$1K	–	123
2021 Q1	$1K	Buy	96 +60	+167%	+$1.23K	﹤0.01%	604
2020 Q4	$0	Buy	+36	New	+$659	﹤0.01%	581

Other funds holding ALKS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Alpha DNA Investment Management's ALKS Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Alkermes (ALKS) in Q3 2023, closing a stake of 22,186 shares — an estimated $694K sold.

Alpha DNA Investment Management first reported a position in ALKS in Q4 2020 and held it in 3 quarters. The position peaked at $694K in Q2 2023. 307 funds tracked by Wall St. Rank hold ALKS as of Q3 2023.

Alpha DNA Investment Management reported no remaining Alkermes position as of Q3 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 22,186 Alkermes shares in Q3 2023, an estimated $694K.
Alpha DNA Investment Management first reported a position in Alkermes in Q4 2020 and held it in 3 quarters.
Alpha DNA Investment Management's Alkermes position peaked at $694K in Q2 2023.
307 funds tracked by Wall St. Rank held Alkermes as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.